Glucorticoids and bone: Some general remarks and some special observations in pediatric patients

Calcified Tissue International

Volumn 70, Issue 5, 2002, Pages 384-390

  Bianchi, Maria Luisa ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIFEDIOL; CALCIUM; GLUCOCORTICOID; VITAMIN D;

ANTIINFLAMMATORY ACTIVITY; BONE DENSITY; BONE METABOLISM; BONE NECROSIS; CALCIUM ABSORPTION; CALCIUM TRANSPORT; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FRACTURE; HIGH RISK POPULATION; HUMAN; HYPOGONADISM; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE ABSORPTION; LONG TERM CARE; OSTEOBLAST; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SECONDARY HYPERPARATHYROIDISM; SIDE EFFECT; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADOLESCENT; BONE; CHEMICALLY INDUCED DISORDER; CHILD; CLASSIFICATION; FEMALE; METABOLISM; NEWBORN; OSTEOPOROSIS; PATHOLOGY;

ADOLESCENT; BONE AND BONES; BONE DENSITY; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; OSTEONECROSIS; OSTEOPOROSIS;

EID: 0036579747     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-001-0043-0     Document Type: Review

References (78)

1. Hench PS, Kendall EC, Slocumb CH, Polley HF (1949) The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 24:181-197
2. Adachi JD, Bensen WG, Hodsman AB (1993) Corticosteroid-induced osteoporosis. Semin Arthritis Rheum 22:375-384
3. Dempster DW (1989) Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 4:137-141
4. Shalhoub V, Conlon D, Tassinari M, Quinn C, Patridge N, Stein GS, Lian JB (1992) Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J Cell Biochem 50:425-440
5. Caputo CB, Meadows D, Frisz LG (1976) Failure of estrogens and androgens to inhibit bone resorption in tissue culture. Endocrinology 98:1065-1068
6. Gronowicz G, McCarthy MB, Raisz IG (1990) Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro. J Bone Miner Res 5:1223-1230
7. 3-induced DNA-dependent RNA polymerase activity in chick intestinal cells. Calcif Tissue Int 40:224-230
8. Shultz TD, Bollman S, Kumar R (1982) Decreased intestinal calcium absorption in vivo and normal brush border membrane vesicle calcium uptake in cortisol-treated chickens: evidence for dissociation of calcium absorption from brush border vesicle uptake. Proc Natl Acad Sci USA 79:3542-3546
9. 3 and glucocorticoids. Endocrinology 128:944-950
10. 22Na transduodenal flux in corticosteroid-treated rats. Miner Electrolyte Metab 4:216-226
11. Glade MJ, Krook I, Schryver HF, Hintz HF (1982) Calcium metabolism in glucocorticoid-treated pony foals. J Nutr 112:77-86
12. Nielsen HK, Thomsen K, Eriksen EF, Charles P, Storm T, Mosekilde L (1988) The effect of high dose of glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone Miner 4:105-113
13. Reid IR, Ibbertson HK (1987) Evidence of decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. Horm Res 27:200-204
14. Adams JS, Wahl TO, Lukert BP (1981) Effects of hydrochlorothaizide and dietary sodium restriction on calcium metabolism in corticosteroid-treated patients. Metabolism 30:217-221
15. Suzuki Y, Ichikawa Y, Saito E, Homma M (1983) Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32:151-156
16. Au WY (1976) Cortisol stimulation of parathyroid hormone secretion by rat parathyroid glands in organ culture. Science 193:1015-1017
17. 2-sensing receptor from bovine parathyroid. Nature 366:575-580
18. MacAdams MR, White RH, Chipps BE (1986) Reduction of serum testosterone levels during chronic glucorticoid therapy. Ann Intern Med 104:648-651
19. Hsueh AJ, Erickson GF (1978) Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells. Steroids 32:639-648
20. Kaufmann S, Jones KL, Wehrenberg WB, Culler FL (1988) Inhibition by prednisone of growth hormone (GH) response to GH-releasing hormone in normal men. J Clin Endocrinol Metab 67:1258-1261
21. Unterman TG, Philips LS (1985) Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 54:885-892
22. Mosier HD Jr, Jansons RA, Hill RR, Dearden LC (1976) Cartilage sulfation and serum somatomedin in rats during and after cortisone-induced growth arrest. Endocrinology 99:580-589
23. Morris HG, Jorgesen JR, Elrick H, Goldsmith RE (1968) Metabolic effects of human growth hormone in corticosteroid-treated children. J Clin Invest 47:436-451
24. Soyka LF (1967) Treatment of the nephrotic syndrome in childhood: use of an alternate-day prednisone regimen. Am J Dis Child 113:693-701
25. Centrella M, McCarthy TL, Canalis E (1991) Glucocorticoid regulation of transforming growth factor B1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol 11:4490-4496
26. Michel BA, Bloch DA, Wolfe F, Fries JF (1993) Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 20:1666-1669
27. Adinoff AD, Holister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309:265-268
28. Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH (1985) Evaluation of factors associated with glucocorticoid-induced osteoporosis in patients with rheumatic diseases. Arthritis Rheum 28:361-368
29. Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G (1986) Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) 293:1463-1466
30. Porayko MK, Wiesner RH, Hay JE, Krom RA, Dickson ER, Beaver S, Schwerman L (1991) Bone disease in liver transplant recipients: incidence, timing and risk factors. Transplant Proc 23(1 Pt 2):1462-1465
31. Sambrook PN, Kelly PJ, Fontana D, Nguyen T, Keogh A, Macdonald P, Spratt P, Freund J, Eisman JA (1994) Mechanism of rapid bone loss following cardiac transplantation. Osteoporosis Int 4:273-276
32. Atkinson SA, Halton JM, Bradley C, Wu B, Barr RD (1998) Bone mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer Suppl 11:35-39
33. Seeman E, Wagner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL (1982) Differential effects of endocrine dysfunction on the axial and appendicular skeleton. J Clin Invest 69:1302-1309
34. Laan R, Buijs W, van Erning L, Lemmens J, Corstens F, Ruijs L, van de Putte L, van Riel P (1993) Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content. Calcif Tissue Int 52:5-9
35. Ortoft G, Oxlund H (1988) Reduced strength of rat cortical bone after glucocorticoid treatment. Calcif Tissue Int 43:376-382
36. Esbjorner E, Arvidsson B, Jones IL, Palmes M (2001) Bone mineral content and collagen metabolites in children receiving steroid treatment for nephrotic syndrome. Acta Paediatr 90:1127-1130
37. Harris M, Hauser S, Nguyen TV, Kelly PJ, Rodda C, Morton J, Freezer N, Strauss BJ, Eisman JA, Walker JL (2001) Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment. J Paediatr Child Health 37:67-71
38. Jones G, Ponsonby AL, Smith BJ, Carmichael A (2000) Asthma, inhaled corticosteroid use, and bone mass in prepubertal children. J Asthma 37:603-611
39. Rao R, Gregson RK, Jones AC, Miles EA, Campbell MJ, Warner JO (1999) Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone. Eur Respir J 13:87-94
40. Semeao EJ, Jawad AF, Stouffer NO, Zeincl BS, Piccoli DA, Stallings VA (1999) Risk factors for low bone mineral density in children and young adults with Crohn's disease. J Pediatr 135:593-600
41. Chiodini I, Carnevale V, Torlontano M, Fusilli S, Gugliclini G, Pileri M, Modoni S, Di Giorgio A, Liuzzi A, Minisola S, Cammisa M, Trischitta V, Sicilitani A (1998) Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab 83:1863-1867
42. Slemenda CW, Reister TK, Hui SL, Miller JZX, Christian JC, Johnston CC (1994) Influences of skeletal mineralization in children and adolescents: evidence for varying effects of sexual maturation and physical activity. J Pediatr 125:201-207
43. Bianchi ML, Bardare M, Caraceni MP, Cohen E, Falvella S, Borzani M, DeGaspari MG (1990) Bone metabolism in juvenile rheumatoid arthritis. Bone Miner 9:153-162
44. Bardare M, Bianchi ML, Furia M, Gandolini GG, Cohen E, Montesano A (1991) Bone mineral metabolism in chronic arthritis: the influence of steroids. Clin Exp Rheumatol 9(Suppl 6):29-31
45. Trapani S, Civinini R, Ermini M, Paci E, Falcini F (1998) Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 18:45-49
46. Nysom K, Holm K, Michaelsen KF, Hertz H, Muller J, Molgaard C (1998) Bone mass after treatment for acute lymphoblastic leukemia in childhood. J Clin Oncol 16:3752-3760
47. Hesseling PB, Hough SF, Nel ED, van Riet FA, Beneke T, Wessls G (1998) Bone mineral density in long-term survivors of childhood cancer. Int J Cancer Suppl 11:44-47
48. Lukert BP, Raisz LG (1994) Glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 20:629-650
49. Lukert BP, Higgins JC, Stokopf MM (1986) Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 62:1056-1058
50. Nielsen HK, Thomsen K, Eriksen EF, Storm T, Mosekilde L (1987) The effect of high-dose glucocorticoid administration on serum gamma carboxyglutamic acid containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone Miner 4:105-108
51. Need AG, Philcox JC, Hartley TF, Nordin BEC (1986) Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women. Aust N Z J Med 16:341-346
52. Ruegsegger P, Medici TC, Anlinker M (1983) Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 25:615-620
53. Reid IR, Heap SW (1990) Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 150:2545-2548
54. Sorva R, Turpeinen M, Juntunen-Backman K, Karonen SL, Sorva A (1992) Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol 90:808-815
55. Gluck OS, Murphy WA, Hahn TJ, Hahn B (1985) Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy. Arthritis Rheum 24:892-898
56. Teelucksingh S, Padfield PL, Tibi L, Gough KJ, Holt PR (1991) Inhaled corticosteroids, bone formation, and osteocalcin. Lancet 2:60-61
57. Horber FF, Scheidegger JR, Grüig BE, Frey FJ (1985) Evidence that prednisone induced myopathy is reversed by physical training. J Clin Endocrinol Metab 61:83-88
58. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Stat M, Pocock N, Eisman J (1993) Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328:1747-1752
59. Foresta C, Ruzza G, Mioni R, Meneghello A, Bacchetti C (1983) Testosterone and bone loss in Klinefelter syndrome. Horm Metab Res 15:56-57
60. Lukert BP, Johnson BE, Robinson R (1992) Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 7:1063-1069
61. American College of Rheumatology Task Force on Osteoporosis Guidelines (1996) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 39:1791-1801
62. Reid IR, King AR, Alexander CJ, Ibbertson HK (1988) Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet 1:143-146
63. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice M-P, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucorticoid-induced osteoporosis. N Engl J Med 339:292-299
64. Wallach S, Cohen S, Reid DM, Highes RA, Hosking DJ, Laan RF, Doherty SM, Maricic M, Rosen C, Brown J, Barton I, Chines AA (2000) Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 67:277-285
65. Falcini F, Trapani S, Ermini M, Brandi ML (1996) Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling. Calcif Tissue Int 58:166-169
66. Lepore L, Pennesi M, Barbi E, Pozzi R (1991) Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate. Clin Exp Rheumatol 9 (Suppl 6):33-35
67. Bianchi ML, Cimaz R, Bardare M, Zulian F, Lepore L, Boncompagni A, Galbiati E, Corona F, Luisetto G, Giuntini D, Picco P, Brandi ML, Falcini F (2000) Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children. Arthritis Rheum 43:1960-1966
68. Mankin HJ (1992) Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 326:1473-1479
69. Davidson JK, Tsakiris D, Briggs JD, Junor BJ (1985) Osteonecrosis and fractures following renal transplantation. Clin Radiol 36:27-35
70. Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB (1985) Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med 79:596-604
71. Jones JP (1985) Fat embolism and osteonecrosis. Orthop Clin North Am 16:595-633
72. Frost HM (1960) Presence of microscopic cracks in vivo in bone. Henry Ford Hosp Med J 8:25
73. Hungerford DS, Lennox DW (1985) The importance of increased intraosseous pressure in the development of osteonecrosis of the femoral head: implications for treatment. Orthop Clin North Am 16:635-654
74. Ojala AE, Paakko E, Lanning FP, Lanning M (1999) Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study. Med Pediatr Oncol 32:11-17
75. Pocock NA, Eisman JA, Dunstan CR, Evans RA, Thomas DH, Huq NL (1987) Recovery from steroid-induced osteoporosis. Ann Intern Med 107:319-323
76. Gray RES, Doherty SM, Galloway J, Coulton L, deBroe M, Kanis JA (1991) A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis Rheum 34:287-295
77. Aicardi G, Milani S, Imbimbo B, Vigoro M (1991) Comparison of growth retarding effects by two different glucocorticoids in prepubertal sick children. Calcif Tissue Int 48:283-287
78. Alien DB, Goldberg BD (1984) Stimulation of collagen synthesis and linear growth hormone in glucocorticoid-treated children. Pediatrics 89:416-421